The BrainSee test avoids traditional Alzheimer's assessments that rely on general biomarkers such as amyloid or tau.

Darmiyan, Inc., a pioneer in brain technology, is proud to announce the launch of the BrainSee Platform, integrating the first-of-its-kind FDA-approved BrainSee Test for Alzheimer's disease. This ...

Reconsolidation has been conceptualized as a post-retrieval process that stabilizes memory made labile by retrieval. This theory remains controversial, and one major question is whether post ...

aDementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK bDepartment of Clinical and Movement Neurosciences, Queen Square Brain Bank for Neurological ...